Among the patients who did not complete therapy there was the patient with the SDHB mutation whose treatment had to be stopped and a male patient of 69 years (with a history of vascular occlusive disease) who died from a cerebral insult 3 weeks after start of imatinib. The gene discussed is SDHB; the disease is Peripheral arterial stenosis.